Rotation Director
Rotation Description
Prerequisites: Applicants must be enrolled in a MD-PhD program and have completed a prior oncology rotation. Medical oncology or malignant hematology is strongly encouraged. Other subspecialties may be considered such as surgical oncology or radiation oncology.
This 3-month rotation in the Center for Cancer Research (CCR) at the National Cancer Institute (NCI) located in Bethesda, MD, is designed for eligible applicants with an appropriate scientific background who seek specialized exposure to and clinical training experience in cancer immunotherapy, with an emphasis on engagement in clinical trials and clinical trial development.
The breadth and depth of exposure to immunotherapy translational research at the NCI are unsurpassed with active clinical trials using approaches such as therapeutic cancer vaccines, immune checkpoint modulation, adoptive cellular therapies (e.g. TCR transgenic and CAR-T therapy) and antibody-based immunotherapies. This rotation also allows participants to have exposure to key opinion leaders in the field of clinical immunotherapy.
Rotation Objective
The primary objective of this rotation is to provide clinical research exposure and additional patient oriented experience for appropriately qualified students with a focus on clinical trial design and conduct; immunotherapy treatment modalities; management of toxicities; and opportunities to work directly with principal investigators in the CCR studying multiple experimental agents.
Selection of Applicants
Applicants must apply at least four (4) months prior to their anticipated start date in order to be considered. Please contact the Clinical Electives Program at cep@nih.gov prior to applying.